COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,184 Articles (22,713 medRxiv, 8,471 bioRxiv)

Most recent first Previous |  Page 2762: Articles 27611-27620  | Next

Establishment of an African green monkey model for COVID-19
Woolsey, C. B., Borisevich, V., Prasad, A. N., Agans, K. N., Deer, D. J., Dobias, N. S., Heymann, J. C., Foster, S. L., Levine, C. B., Medina, L., Melody, K., Geisbert, J. B., Fenton, K. A., Geisbert, T. W., Cross, R. W.
10.1101/2020.05.17.100289 — Posted: 2020-05-17
Nrf2 Activator PB125 as a Potential TherapeuticAgent Against COVID-19
McCord, J. M., Hybertson, B. M., Cota-Gomez, A., Gao, B.
10.1101/2020.05.16.099788 — Posted: 2020-05-17 Discussion: Onsite
Epitope-Based Peptide Vaccine Against Severe Acute Respiratory Syndrome-Coronavirus-2 Nucleocapsid Protein: An in silico Approach
Rakib, A., Sami, S. A., Islam, M. A., Ahmed, S., Faiz, F. B., Khanam, B. H., Uddin, M. M. N., Emran, D. T. B.
10.1101/2020.05.16.100206 — Posted: 2020-05-17
Binding of the SARS-CoV-2 Spike Protein to Glycans
Hao, W., Ma, B., Li, Z., Wang, X., Gao, X., Li, Y., Qin, B., Shang, S., Cui, S., Tan, Z.
10.1101/2020.05.17.100537 — Posted: 2020-05-17 Discussion: Onsite
Robust computational design and evaluation of peptide vaccines for cellular immunity with application to SARS-CoV-2
Liu, G., Carter, B., Bricken, T., Jain, S., Viard, M., Carrington, M., Gifford, D. K.
10.1101/2020.05.16.088989 — Posted: 2020-05-17
SARS-CoV-2 amino acid substitutions widely spread in the human population are mainly located in highly conserved segments of the structural proteins
Cortey, M., Li, Y., Diaz, I., Clilverd, H., Darwich, L., Mateu, E.
10.1101/2020.05.16.099499 — Posted: 2020-05-17
The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States
Laise, P., Bosker, G., Sun, X., Shen, Y., Douglass, E. F., Karan, C., Realubit, R. B., Pampou, S., Califano, A., Alvarez, M. J.
10.1101/2020.05.12.091256 — Posted: 2020-05-17
Molecular conservation and Differential mutation on ORF3a gene in Indian SARS-CoV2 genomes
Hassan, S. S., Pal Choudhury, P., Basu, P., Jana, S. S.
10.1101/2020.05.14.096107 — Posted: 2020-05-17
Understanding the indoor pre-symptomatic transmission mechanism of COVID-19
Arav, Y., Klausner, Z., Fattal, E.
10.1101/2020.05.12.20099085 — Posted: 2020-05-17
FORECASTING COVID-19 PANDEMIC: A DATA-DRIVEN ANALYSIS
Nabi, K. N.
10.1101/2020.05.12.20099192 — Posted: 2020-05-17 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).